The development and characterization of a human midgut carcinoid cell line

Clinical Cancer Research

Volumn 13, Issue 16, 2007, Pages 4704-4712

  Van Buren II, George ^a   Rashid, Asif ^a   Yang, Anthony D ^a   Abdalla, Eddie K ^a   Gray, Michael J ^a   Liu, Wenbiao ^a   Somcio, Ray ^a   Fan, Fan ^a   Camp, E Ramsay ^a   Yao, James C ^a   Ellis, Lee M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CHROMOGRANIN A; EPIDERMAL GROWTH FACTOR RECEPTOR; NEUROPILIN 1; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SCATTER FACTOR RECEPTOR; SOMATOMEDIN C RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5; SYNAPTOPHYSIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; CANCER CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; CYTOGENETICS; ELECTRON MICROSCOPY; ENZYME IMMUNOASSAY; FEMALE; GASTROINTESTINAL TRACT; GENE DELETION; GENE TRANSLOCATION; HUMAN; ILEUM CANCER; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MIDGUT; MONOLAYER CULTURE; NEUROENDOCRINE TUMOR; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOID; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; CARCINOID TUMOR; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; ILEAL NEOPLASMS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SEROTONIN; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34548065167     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-2723     Document Type: Article

References (39)

1. Leotlela PD, Jauch A, Holtgreve-Grez H, Thakker RV. Genetics of neuroendocrine and carcinoid tumours. Endocr Relat Cancer 2003;10:437-50.
2. Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 2005;128:1717-51.
3. Schnirer II, Yao JC, Ajani JA. Carcinoid - a comprehensive review. Acta Oncol 2003;42:672-92.
4. de Herder WW. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome). Best Pract Res Clin Gastroenterol 2005;19:705-15.
5. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-59.
6. Oberg K. Diagnosis and treatment of carcinoid tumors. Expert Rev Anticancer Ther 2003;3:863-77.
7. Buchan AM, Polak JM. The classification of the human gastroenteropancreatic endocrine cells. Invest Cell Pathol 1980;3:51-71.
8. Solcia E, Capella C, Buffa R, Fiocca R, Frigerio B, Usellini L. Identification, ultrastructure and classification of gut endocrine cells and related growths. Invest Cell Pathol 1980;3:37-49.
9. Solcia E, Capella C, Buffa R, Usellini L, Frigerio B, Fontana P. Endocrine cells of the gastrointestinal tract and related tumors. Pathobiol Annu 1979;9:163-204.
10. Van Eeden S, Quaedvlieg PF, Taal BG, Offerhaus GJ, Lamers CB, Van Velthuysen ML. Classification of low-grade neuroendocrine tumors of midgut and unknown origin. Hum Pathol 2002;33:1126-32.
11. Zikusoka MN, Kidd M, Eick G, Latich I, Modlin IM. Themolecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer 2005;104:2292-309.
12. Kytola S, Hoog A, Nord B, et al. Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids. Am J Pathol 2001;158:1803-8.
13. Parekh D, Ishizuka J, Townsend CM Jr, et al. Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion. Pancreas 1994;9:83-90.
14. Brandt DW, Pandol SJ, Deftos LJ. Calcium-stimulated parathyroid hormone-like protein secretion: potentiation through a protein kinase-C pathway. Endocrinology 1991;128:2999-3004.
15. Debons-Guillemin MC, Launay JM, Roseto A, Peries J. Serotonin and histamine production by human carcinoid cells in culture. Cancer Res 1982;42:1513-6.
16. Westberg G, Ahlman H, Nilsson O, Illerskog A, Wangberg B. Secretory patterns of tryptophan metabolites in midgut carcinoid tumor cells. Neurochem Res 1997;22:977-83.
17. Konno H, Arai T, Tanaka T, et al. Antitumor effect of a neutralizing antibody to vascular endothelial growth factor on liver metastasis of endocrine neoplasm. Jpn J Cancer Res 1998;89:933-9.
18. Kolby L, Bernhardt P, Ahlman H, et al. A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake. Am J Pathol 2001;158:745-55.
19. Kolby L, Bernhardt P, Johanson V, et al. Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour. Br J Cancer 2005;93:1144-51.
20. Muller HK, Bucana CD, Kripke ML, Cox PA, Saijo S, Strickland FM. Ultraviolet irradiation of murine skin alters cluster formation between lymph node dendritic cells and specific T lymphocytes. Cell Immunol 1994;157:263-76.
21. Jung YD, Liu W, Reinmuth N, et al. Vascular endothelial growth factor is upregulated by interleukin-1β in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway. Angiogenesis 2001;4:155-62.
22. Pathak S. Chromosome banding techniques. J Reprod Med 1976;17:25-8.
23. Liu W, Ahmad SA, Jung YD, et al. Coexpression of ephrin-Bs and their receptors in colon carcinoma. Cancer 2002;94:934-9.
24. Jung YD, Nakano K, Liu W, Gallick GE, Ellis LM. Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells. Cancer Res 1999;59:4804-7.
25. Fossmark R, Martinsen TC, Qvigstad G, et al. Ultrastructure and chromogranin A immunogold labelling of ECL cell carcinoids. APMIS 2005;113:506-12.
26. Paraskevakou H, Saetta A, Skandalis K, Tseleni S, Athanassiadis A, Davaris PS. Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids. Pathol Oncol Res 1999;5:205-10.
27. Sippel RS, Carpenter JE, Kunnimalaiyaan M, Lagerholm S, Chen H. Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells. Am J Physiol Gastrointest Liver Physiol 2003;285:G245-54.
28. Wilander E, Scheibenpflug L. Cytokeratin expression in small intestinal and appendiceal carcinoids. A basis for classification. Acta Oncol 1993;32:131-4.
29. Tonnies H, Toliat MR, Ramel C, et al. Analysis of sporadicn euroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation. Gut 2001;48:536-41.
30. Gupta S, Johnson MM, Murthy R, et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 2005;104:1590-602.
31. Moertel CG. Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol 1983;1:727-40.
32. Ferrara N, Hillan KJ, Novotny W. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 2005;333:328-35.
33. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005;23:1011-27.
34. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
35. Fan F, Wey JS, McCarty MF, et al. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene 2005;24:2647-53.
36. Yang AD, Camp ER, Fan F, et al. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res 2006;66:46-51.
37. Wey JS, Fan F, Gray MJ, et al. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer 2005;104:427-38.
38. Wey JS, Gray MJ, Fan F, et al. Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. Br J Cancer 2005;93:233-41.
39. Parikh AA, Liu WB, Fan F, et al. Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma. Cancer 2003;98:720-9.